Integrated Biomarker Assessment for Prognosis in Canine Mammary Carcinomas: Complementary Roles of Serum CA 15-3 and Immunohistochemistry Ki-67, and COX-2 [PDF]
AnimalsCMTs are biologically heterogeneous neoplasms for which reliable prognostic biomarkers remain limited. This study investigated the clinical significance of serum cancer antigen 15-3 (CA 15-3) and the immunohistochemical expression of Ki-67 and ...
Breno Queiroz Pinheiro +6 more
doaj +2 more sources
Sensitive determination of breast cancer biomarker, CA 15-3, using a label free electrochemical aptasensor based on palladium nanoparticles decorated carbon nanofibers [PDF]
Scientific ReportsThis study introduces an electrochemical aptasensor for the sensitive determination of the breast cancer biomarker, carbohydrate antigen 15–3 (CA 15-3).
Maryam Nayeri +2 more
doaj +2 more sources
CA-19-9 as an Emerging Marker of Ovarian Tumour: A Rare Entity [PDF]
Journal of Clinical and Diagnostic Research, 2019 Tumour markers are widely used in clinical practice for diagnosis; follow-up, prognosis and to predict recurrence of certain malignancies. Markers for ovarian cancer include CA-125 antigen, CA-15-3 antigen, and Carcino-Embryonic Antigen (CEA).
Alpana Singh +4 more
doaj +1 more source
Correlation between CA-15-3 and Bone Scan findings in patients with Carcinoma Breast
Asian Pacific Journal of Cancer Biology, 2022 Objectives: Breast cancer is the most common malignant tumor of females; the incidence increases with age. Bone is the most common site to which breast cancer metastasizes.
Julekha Khatun, Tarim Mahmood
doaj +1 more source
Assessment of CEA and CA15-3 as Potential Prognostic Markers for Breast Cancer in Egyptian Females. [PDF]
Alfarama Journal of Basic & Applied Sciences, 2021 Background: Breast cancer is the most prevalent cancer and one of the most common mortality causes among females worldwide. Accordingly, it is a main concern of scientists and doctors. Evolving serum tumor markers helping to early diagnosis of the breast
mohamed ibrahim mosa +3 more
doaj +1 more source
Cancer Treatment and Research Communications, 2021 Background: We aimed to evaluate the association of serum carcinoembryonic antigen (CEA) and cancer antigen 15–3 (CA 15–3) levels with clinicopathological parameters in patients with breast cancer (BC) and their efficiency for the prediction of ...
Meliha Melin Uygur, Mahmut Gümüş
doaj +1 more source
Breast, 2020 Background: Serum tumour markers, cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) are not routinely recommended for detecting breast cancer recurrence and monitoring treatment. In this study, we aim to evaluate the diagnostic accuracy of
J.X. Hing +6 more
doaj +1 more source
Electrochemical immunosensor for detection of CA 15-3 biomarker in point-of-care
Sensing and Bio-Sensing Research, 2021 This work reports the development of a simple and rapid electrochemical immunosensor for the determination of breast cancer biomarker Cancer Antigen 15–3 (CA 15–3). Disposable and cost-effective chips, consisting of gold screen-printed electrodes (AuSPEs)
Tânia S.C.R. Rebelo +3 more
doaj +1 more source
Tumor Markers in Dogs with Mammary Gland Tumors
Acta Veterinaria, 2023 The aim of this study was to determine and compare values of carcinoembryonic antigen (CEA) and cancer antigen (CA 15-3) in 50 bitches with mammary tumors and 150 clinically healthy dogs.
Valencakova Alexandra +4 more
doaj +1 more source
New Quantum-Dot-Based Fluorescent Immunosensor for Cancer Biomarker Detection
Chemosensors, 2022 Cancer antigen 15-3 (CA 15-3) is a biomarker for breast cancer used to monitor response to treatments and disease recurrence. The present work demonstrates the preparation and application of a fluorescent biosensor for ultrasensitive detection of the ...
Mariana P. Sousa +5 more
doaj +1 more source